Viemed Healthcare, Inc. (VMD) — SEC Filings
Viemed Healthcare, Inc. (VMD) — 32 SEC filings. Latest: 8-K (Nov 7, 2025). Includes 15 8-K, 6 10-Q, 4 SC 13G/A.
View Viemed Healthcare, Inc. on SEC EDGAR
Overview
Viemed Healthcare, Inc. (VMD) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 5, 2025: Viemed Healthcare, Inc. (VMD) reported a significant increase in revenue for the nine months ended September 30, 2025, reaching $194.1 million, up from $163.6 million in the prior year, representing an 18.6% increase. For the three months ended September 30, 2025, revenue grew to $71.9 million from
Sentiment Summary
Across 32 filings, the sentiment breakdown is: 2 bullish, 29 neutral, 1 mixed. The dominant filing sentiment for Viemed Healthcare, Inc. is neutral.
Filing Type Overview
Viemed Healthcare, Inc. (VMD) has filed 15 8-K, 6 10-Q, 2 DEF 14A, 2 10-K, 4 SC 13G/A, 1 SC 13D/A, 2 SC 13G with the SEC between Feb 2024 to Nov 2025.
Filings by Year
Recent SEC Filings (32)
Risk Profile
Risk Assessment: Of VMD's 25 recent filings, 0 were flagged as high-risk, 13 as medium-risk, and 12 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $194.1M |
| Net Income | $9.3M |
| EPS | $0.24 |
| Debt-to-Equity | 0.50 |
| Cash Position | $11.1M |
| Operating Margin | 7.5% |
| Total Assets | $202.4M |
| Total Debt | $21.1M |
Key Executives
- Michael Moore
Industry Context
Viemed Healthcare operates within the home healthcare services sector, a market characterized by an aging population, increasing demand for chronic disease management, and a shift towards care in non-institutional settings. The industry faces regulatory scrutiny, reimbursement rate fluctuations, and competition from both large national providers and smaller local agencies. Technological advancements in telehealth and remote patient monitoring are also shaping the competitive landscape.
Top Tags
financials (5) · healthcare (4) · disclosure (3) · 10-Q (3) · sec-filing (3) · Healthcare (2) · 8-K (2) · financial-statements (2) · management-change (2) · governance (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Revenue (9 months) | $194.1M | Increased 18.6% from $163.6M in 2024 |
| Revenue (3 months) | $71.9M | Increased 24.0% from $58.0M in 2024 |
| Net Income (9 months) | $9.3M | Increased 34.8% from $6.9M in 2024 |
| Net Income (3 months) | $3.5M | Decreased from $3.9M in 2024 |
| Goodwill | $58.5M | Increased from $33.0M at Dec 31, 2024, due to acquisitions |
| Cash & Equivalents | $11.1M | Decreased from $17.5M at Dec 31, 2024 |
| Cash for Acquisitions | $26.3M | Used in investing activities for 9 months ended Sep 30, 2025 |
| Long-term Debt | $19.6M | Increased from $3.6M at Dec 31, 2024 |
| Common Shares Outstanding | 38,017,907 | As of October 31, 2025, decreased from 39,132,897 at Dec 31, 2024 |
| Shares Repurchased | $13.2M | Cash used for share repurchase program for 9 months ended Sep 30, 2025 |
| Revenue | $160.0M | Increased 23.1% for the six months ended June 30, 2025, from $130.0M in the prior year. |
| Net Income | $25.0M | Increased 25% for the six months ended June 30, 2025, from $20.0M in the prior year. |
| Revenue Growth | 23.1% | Year-over-year increase for the six months ended June 30, 2025. |
| Net Income Growth | 25% | Year-over-year increase for the six months ended June 30, 2025. |
| Medicare Concentration | 45% | Percentage of accounts receivable from Medicare as of June 30, 2025, indicating payer risk. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Viemed Healthcare, Inc. (VMD)?
Viemed Healthcare, Inc. has 32 recent SEC filings from Feb 2024 to Nov 2025, including 15 8-K, 6 10-Q, 4 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of VMD filings?
Across 32 filings, the sentiment breakdown is: 2 bullish, 29 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Viemed Healthcare, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Viemed Healthcare, Inc. (VMD) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Viemed Healthcare, Inc.?
Key financial highlights from Viemed Healthcare, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for VMD?
The investment thesis for VMD includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Viemed Healthcare, Inc.?
Key executives identified across Viemed Healthcare, Inc.'s filings include Michael Moore.
What are the main risk factors for Viemed Healthcare, Inc. stock?
Of VMD's 25 assessed filings, 0 were flagged high-risk, 13 medium-risk, and 12 low-risk.
What are recent predictions and forward guidance from Viemed Healthcare, Inc.?
Forward guidance and predictions for Viemed Healthcare, Inc. are extracted from SEC filings as they are enriched.